ICB-PHARMA 2021 - The 4th International Conference Current Breakthrough in Pharmacy

14-15 January 2022
in conjunction with
International Summit on Science Technology and Humanity (ISETH2021)

You have to login to submit ICB-Pharma 2021 papers.
For the first time user, you need to create author account.
If you forgot your password, request new password.

Introduction

Welcome to the fourth International Conference of Current Breakthrough in Pharmacy. This year, our conference will be held virtually by Zoom Conference.
The 4th ICB-Pharma (The 4th International Conference Current Breakthrough in Pharmacy) invites all potential authors from universities and various organisations to submit papers in the area of pharmacy. This conference is part of a conference program called International Summit on Science Technology and Humanity (ISETH) 2021 Organized by Universitas Muhammadiyah Surakarta.

Theme

Pharmaceutical Development in the post-Covid-19 Era

Speakers

Prof. Dr. Muhammad Da'i, M.Si, Apt
(Universitas Muhammadiyah Surakarta, Indonesia)		 Assoc. Prof. Dr. Fazlin Mohd Fauzi
(Universiti Teknologi MARA (UiTM), Malaysia)		 Assoc. Prof. Dr. Yupaporn Preechagoon
(Khon Kaen University, Thailand)		 Akira Kurisaki, Ph.D.
(Nara Institute of Science and Technology (NAIST), Japan)

Invited Speakers

Assoc. Prof. Dr. Fahad Saleem
(University of Balochistan, Quetta, Pakistan)		 Dr. Md. Sanower Hossain
(International Islamic University Malaysia)		 Assoc Prof. Dr. Mohammed Akhmad Aslam
(Umm Al-Qura University, Makkah)

Focus and Scope

 

Pharmaceutics and Applied Materials for Drug Delivery
Pharmacology and Toxicology
Pharmacy Practices and Clinical Pharmacy
Medicinal and Pharmaceutical Chemistry
Pharmacognosy & Ethnobotany
Biotechnology and Microbiology

Important Dates

Information Important Dates
20 30 Dec 2021 14 Jan 2022 Full Paper Submission Deadline
27 Dec 7 Jan 2021 Notification of Full Paper Acceptance
4 January 2022 Notification of Review Result
11 January 2022 Submission of Revised Papers
5 - 13 January 2022 Payment Session

Collaborations

               http://journals.ums.ac.id/index.php/pharmacon  

Publication Fee(s)

Participant Category Overseas Indonesian
General Presenter 40 USD 500,000 IDR
Undergraduate Student 15 USD 200,000 IDR
Non-Presenters 5 USD 100,000 IDR
Additional Paper 15 USD 200,000 IDR
Additional Presenter* 15 USD 200,000 IDR

 

Upload your Payment Proof for Registration only in this link

 

* One paper can be presented no more than 2 presenters

Additional information:

  • Selected papers will be published either by accordingly with the focus and scope. The selected papers will be charged additional publication fee as much as 2,000,000 IDR.
  • The payment can be made in the following bank account information:

 

Bank Name: Bank Negara Indonesia
Account Number: 3500750033
Account Holder: Fakultas Farmasi UMS
Swift: BNINIDJAXXX

The 4th International Current Breakthrough in Pharmacy
Conference Chair: Peni Indrayudha, S.F, M.Biotech, Apt, Ph.D.

Track 1: Pharmaceutics and Applied Materials for Drug Delivery

Track Director: Anita Sukmawati, S.Si., Apt., M.Si., Ph.D.

• Physical pharmacy • pharmaceutics • pharmaceutical technology • drug delivery • pharmaceutical engineering • materials science • nanotechnology • novel development in manufacturing • concept of Quality by Design in pharmaceutical product

Track 2: Pharmacology and Toxicology

Track Director: Zakky Cholisoh, S.Si., M.Clin.Pha, Ph.D.

• Experimental animal pharmacology and toxicology • biochemical cellular pharmacology and toxicology • pharmacokinetics • pharmacodynamics, computational prediction of pharmacology • randomised controlled trial • pharmacogenetics • and all aspects of microbiology.

Track 3: Pharmacy Practices and Clinical Pharmacy

Track Director: Hidayah Karuniawati, S.Farm., M.Sc., Apt.

• Social Pharmacy • Pharmacoeconomics • Pharmacoepidemiology • Pharmacy Management • Pharmacy Practice • Health Related Quality of Life Studies • Hospital pharmacy • Community pharmacy • Public health pharmacy • Clinical medicines • Medication counseling • Therapeutic drug monitoring • Parenteral nutrition • Ambulatory care pharmacy • Oncology pharmacy.

Track 4: Medicinal and Pharmaceutical Chemistry

Track Director: Ika Trisharyanti Dian Kusumowati, S.Si, M.Farm, Apt.

• Pharmaceutical Analysis • Environmental Analysis • Biomedical and Biomolecular Analysis • Analytical instrumentation and Methods • Food Analysis • Biosensor, Biochemistry • Medicinal Chemistry.

Track 5: Pharmacognosy & Ethnobotany

Track Director: Rima Munawaroh, S.Si., M.Sc, Apt.

• The structural and chemical characterization • the metabolic pathways leading to the synthesis of pharmacologically active compounds • the significance of natural substances in pharmaceutical research • the introducing different ways of applying plant drugs • the effect and use of drugs, herbal extracts and isolated compounds • the collection and cultivation of medicinal plants • breeding strategies and the application of biotechnology • traditional plant usage for food and fodder plants • medicinal plants • fibers and dyeing plants •   the use herbs to treat illness or applying them in a variety of ways.

Track 6: Biotechnology and Microbiology

Track Director: Maryati, M.Si, Ph.D, S.Si, Apt

• Angiogenesis • invasion and metastasis • antiproliferative • cell cycle • apoptosis • anticancer • immunomodulator • antioxidant • immunotherapy • chemotherapy • carcinogenesis • cancer stem cell • molecular docking • molecular oncology • cancer metabolism • cancer immunology • cancer pharmacogenomic and pharmacogenetic • diagnostics • pharmacotherapy • pharmacoepidemiology • nutraceuticals • cosmeceuticals.

Organising Committee

Patron
apt. Erindyah Retno Wikantyasning, Ph.D
(Universitas Muhammadiyah Surakarta, Indonesia)

Advisory Board
Prof. Dr. Muhammad Da'i, M.Si, Apt
(Universitas Muhammadiyah Surakarta, Indonesia)

Assoc. Prof. Dr. Shariza Sahudin
(Universiti Teknologi MARA (UiTM), Malaysia

Assoc. Prof. Dr. Yupaporn Preechagoon
(Khon Kaen University, Thailand)

Akira Kurisaki, Ph.D.
(Nara Institute of Science and Technology (NAIST), Japan)

apt. Erindyah Retno Wikantyasning, Ph.D
(Universitas Muhammadiyah Surakarta, Indonesia)

Reviewer
Prof. Dr. Muhammad Da'i, M.Si, Apt
(Universitas Muhammadiyah Surakarta, Indonesia)

Dr. Purushotam Selvakumar, Ph.D
(Weill Cornell Medical Collage, New York, US)

Assist. Prof. Hyo Jung Lori Kim, Ph.D
(College of Pharmacy, Woosuk University, Wanju, South Korea)

Dr. Zehra Edis
(Ajman University, UAE)

Dr. Dario Balacco
(University of Birmingham, UK)

Assist. Prof. Dr. Mohammed Akhmad Aslam
(Umm Al-Qura University, Saudi Arabia)

Associate Prof. Dr. Fahad Saleem
(University of Balochistan, Pakistan)

apt. Wahyu Utami, M.Si
(Universitas Muhammadiyah Surakarta, Indonesia)

Confererence chair
apt. Peni Indrayudha, M.Biotech, Ph.D  (Universitas Muhammadiyah Surakarta, Indonesia)

Secretariat
apt. Cita Hanif Muflihah, M.Sc (Universitas Muhammadiyah Surakarta, Indonesia)

Treasurer
apt. Dra. Nurul Mutmainah, M.Si (Universitas Muhammadiyah Surakarta, Indonesia)

Event division
apt. Arini Fadhilah, M.Si (Universitas Muhammadiyah Surakarta, Indonesia)
apt. Juwita Rahmawati, M.Farm (Universitas Muhammadiyah Surakarta, Indonesia)

Documentatition
apt. Setyo Nurwaeni, M.Sc (Universitas Muhammadiyah Surakarta, Indonesia)
apt. Ahmad Fauzi, M.Farm (Universitas Muhammadiyah Surakarta, Indonesia)
Binar Kurnia Sari, S.T (Universitas Muhammadiyah Surakarta, Indonesia)

Scientific committee coordinator
apt. Arifah Sri Wahyuni, M.Sc (Universitas Muhammadiyah Surakarta, Indonesia)
apt. Lilla Prapdhani Agni Hajma, M.Clin. Pharm (Universitas Muhammadiyah Surakarta, Indonesia)
apt. Refsya Azanti Putri, M.S.Farm (Universitas Muhammadiyah Surakarta, Indonesia)

Track director

Track 1: Pharmaceutics and Applied Materials for Drug Delivery 
apt. Anita Sukmawati, M.Si, Ph.D (Universitas Muhammadiyah Surakarta, Indonesia)

Track 2: Pharmacology, Toxicology  and Microbiology 
apt. Zakky Cholisoh, M.Clin.Pharm, Ph.D (Universitas Muhammadiyah Surakarta, Indonesia)

Track 3: Pharmacy Practices and Clinical Pharmacy
apt. Hidayah Karuniawati, M.Sc (Universitas Muhammadiyah Surakarta, Indonesia)

Track 4: Medicinal and Pharmaceutical Chemistry 
apt. Ika Trisharyanti DK, M.Farm (Universitas Muhammadiyah Surakarta, Indonesia)

Track 5: Pharmacognosy & Ethnobotany
Dr. apt. Rima Munawaroh, M.Sc (Universitas Muhammadiyah Surakarta, Indonesia)

Track 6: Cancer Chemoprevention
apt. Maryati, Ph.D (Universitas Muhammadiyah Surakarta, Indonesia)

Day 1 (14 January 2022)
No Time Sessions
1 07.30-08.00 Sign up for Zoom Meeting for the conference participants
2 08.00-08.10 Opening of ISETH 2021
Al Qur'an Recital
3 08.10-08.30 Opening remarks:
apt. Erindyah Retno Wikantyasning, Ph.D (The Dean of Faculty of Pharmacy of Universitas Muhammadiyah Surakarta, Indonesia)
4 08.30-08.40 Break for panel preparation
5 Panel Session
08.40-09.40 Prof. Dr. Muhammad Da'i, M.Si, Apt
(Universitas Muhammadiyah Surakarta, Indonesia)
09.40-10.40 Assoc. Prof. Dr. Fazlin Mohd Fauzi
(Universiti Teknologi MARA (UiTM), Malaysia)
6 10.40 – 11.30 Question and Answer Session
7 11.30 – 12.00 Closing
Day 2 (15 January 2022)
No Time Sessions
1 07.30-08.00 Sign up for Zoom Meeting for the conference participants
2 08.00-08.10 Opening of The 4th ICB-Pharma 2021
Al Qur'an Recital
3 08.10-08.30 Opening remarks:
apt. Erindyah Retno Wikantyasning, Ph.D (The Dean of Faculty of Pharmacy of Universitas Muhammadiyah Surakarta, Indonesia)
4 08.30-08.40 Break for panel preparation
5 Panel Session
08.40-09.40 Assoc. Prof. Dr. Yupaporn Preechagoon
(Khon Kaen University, Thailand)
09.40-10.40 Akira Kurisaki, Ph.D.
(Nara Institute of Science and Technology (NAIST), Japan)
6 10.40-11.30 Question and Answer Session
7 11.30-12.00 Closing and announcement for the parallel session
8 Parallel Session
13.00-16.00 Online parallel session
About Atlantis Press

The The 4th International Conference Current Breakthrough in Pharmacy has agreed with the Atlantis Press Part of Springer to cooperate with the publication of proceedings articles submitted to The 4th International Conference Current Breakthrough in Pharmacy on the scope as described in HOME. The selected papers will be published in the proceeding series Atlantis Highlights in Chemistry and Pharmaceutical Sciences.

The proceedings series Atlantis Highlights in Chemistry and Pharmaceutical Sciences aims to publish high-quality peer-reviewed proceedings from conferences on both experimental and theoretical disciplines of chemical and pharmaceutical sciences. For the accepted scope can be seen in the following table:

  • Pharmaceutics and Applied Materials for Drug Delivery
  • Pharmacology and Toxicology
  • Pharmacy Practices and Clinical Pharmacy
  • Medicinal and Pharmaceutical Chemistry
  • Pharmacognosy & Ethnobotany
  • Biotechnology and Microbiology

Indexation

All articles published in proceedings in this series are submitted for indexation in CPCI (part of Clarivate’s Web of Science), CNKI, Wanfang Data and Google Scholar. Where applicable, they are also submitted to Ei Compendex and Scopus.

Term and Conditions

Term and condition to publish an article to the Atlantis Press Part of Springer:

  • Register as a presenter for the Atlantis Press Part of Springer on the Registration page
  • Manuscripts must be in proper English
  • Pass the similarity test of at least 25% (tested by the committee)
  • Using the AP Conference Proceedings template which can be accessed in the front page
  • Willing to make every effort to revise the paper according to reviewer input within the specified time
  • Papers selected to be recommended for publication by the Atlantis Press Part of Springer will be announced after the conference has been held
  • Papers that do not match the template and do not pass the similarity test will be cancelled by the committee
  • The decision by the jury regarding the announcement of the acceptance of the article cannot be contested
  • Articles that pass will be charged a publication fee of IDR 2.000.000
  • Meanwhile, articles that do not pass will be given the option to be published in the ISSN Proceedings (Free) or may be withdrawn

Poster Guidelines

  1. The poster must be easily read through the computer screen. Design it as attractive as possible.
  2. The poster is made in .jpg format, aspect ratio is 16:9 with landscape orientation, using Powerpoint program. Please provide free space on the lower right of the poster.
  3. Participants also had to make a presentation video.
  4. The maximum duration is 1-2 minutes using the record slide show in PowerPoint.
  • Prepare the file and choose slide show menu on powerpoint.
  • Choose record slide show, and record from current slide
  • The screen now shows your presentation slide and your video on the lower right.
  • Click Record on the upper left to start recording, please remember the maximum duration of the video
  • After finalized the recording, click Stop and click escape to end slide show mode.
  • Choose File, and then click save as. Type file name, and choose MPEG-4 Video (*.mp4) and then save it.
  • Rename the file "PP_video/jpg_presenter name"
  • The video sent by email to: [email protected]

Ethical guidelines for journal publication

 

Publisher is committed to ensuring ethics in publication and quality of articles.
Conformance to standards of ethical behavior is therefore expected of all parties involved: Authors, Editors, Reviewers, and the Publisher.

In particular,
Authors: Authors should present an objective discussion of the significance of research work as well as sufficient detail and references to permit others to replicate the experiments. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. Review articles should also be objective, comprehensive, and accurate accounts of the state of the art. The authors should ensure that their work is entirely original works, and if the work and/or words of others have been used, this has been appropriately acknowledged. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. Authors should not submit articles describing essentially the same research to more than one journal. The corresponding author should ensure that there is a full consensus of all co-authors in approving the final version of the paper and its submission for publication.

Editors: Editors should evaluate manuscripts exclusively on the basis of their academic merit. An editor must not use unpublished information in the editor's own research without the express written consent of the author. Editors should take reasonable responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper.

Reviewers: Any manuscripts received for review must be treated as confidential documents. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviews should be conducted objectively, and observations should be formulated clearly with supporting arguments, so that authors can use them for improving the paper. Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers

Article withdraw policy
It is a general principle of scholarly communication that the editor/guest editor of a learned journal/series is solely and independently responsible for deciding which articles submitted to the journal shall be published. In making this decision the editor/guest editor is guided by policies of the journal's editorial board and constrained by such legal requirements in force regarding libel, copyright infringement and plagiarism. An outcome of this principle is the importance of the scholarly archive as a permanent, historic record of the transactions of scholarship. Articles that have been published shall remain extant, exact and unaltered as far as is possible. However, very occasionally circumstances may arise where an article is published that must later be retracted or even removed. Such actions must not be undertaken lightly and can only occur under exceptional circumstances, such as:

Article Withdrawal:
Only used for Articles in Press which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, but less frequently, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like.
Article Retraction:
Infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Occasionally a retraction will be used to correct errors in submission or publication.
Article Removal:
Legal limitations upon the publisher, copyright holder or author(s).
Article Replacement:
Identification of false or inaccurate data that, if acted upon, would pose a serious health risk.

 

The 4th International Current Breakthrough in Pharmacy (ICB-Pharma) 2021 implements a peer-review policy of single-blind review, where each paper will be evaluated and reviewed in layers. The proceedings editor will evaluate the submitted paper to determine its suitability with the conference focus and scope. Once the paper is declared accepted by the committee, it is sent to two independent expert reviewers. Their role is to review and recommend whether the paper is suitable enough to be published by the Atlantis Press. After going through all these processes and declared recommendations by reviewers, the paper can be submitted to Atlantis Press for publication.